Learning Carbohydrate Digestion and Insulin Absorption Curves Using Blood Glucose Level Prediction and Deep Learning Models.
Mario Muñoz-OrganeroPaula Queipo-ÁlvarezBoni García GutiérrezPublished in: Sensors (Basel, Switzerland) (2021)
Type 1 diabetes is a chronic disease caused by the inability of the pancreas to produce insulin. Patients suffering type 1 diabetes depend on the appropriate estimation of the units of insulin they have to use in order to keep blood glucose levels in range (considering the calories taken and the physical exercise carried out). In recent years, machine learning models have been developed in order to help type 1 diabetes patients with their blood glucose control. These models tend to receive the insulin units used and the carbohydrate taken as inputs and generate optimal estimations for future blood glucose levels over a prediction horizon. The body glucose kinetics is a complex user-dependent process, and learning patient-specific blood glucose patterns from insulin units and carbohydrate content is a difficult task even for deep learning-based models. This paper proposes a novel mechanism to increase the accuracy of blood glucose predictions from deep learning models based on the estimation of carbohydrate digestion and insulin absorption curves for a particular patient. This manuscript proposes a method to estimate absorption curves by using a simplified model with two parameters which are fitted to each patient by using a genetic algorithm. Using simulated data, the results show the ability of the proposed model to estimate absorption curves with mean absolute errors below 0.1 for normalized fast insulin curves having a maximum value of 1 unit.
Keyphrases
- blood glucose
- glycemic control
- type diabetes
- deep learning
- machine learning
- weight loss
- insulin resistance
- cardiovascular disease
- blood pressure
- artificial intelligence
- ejection fraction
- case report
- emergency department
- newly diagnosed
- skeletal muscle
- dna methylation
- convolutional neural network
- genome wide
- current status
- chronic kidney disease
- electronic health record
- copy number
- quality improvement
- adverse drug